Skip to main content
. Author manuscript; available in PMC: 2008 Feb 1.
Published in final edited form as: Neurobiol Dis. 2006 Nov 16;25(2):309–318. doi: 10.1016/j.nbd.2006.09.012

Fig. 6.

Fig. 6

Mean EABR thresholds in each group at 3 days and weeks 1-6 after the onset of deafening. The vertical bars indicate one standard deviation. Mean EABR thresholds in the control group are stable throughout the experiment. EABR thresholds in treated group with high (10mg/kg/day Trolox and 200mg/kg/day ascorbic acid) and low dose (1mg/kg/day Trolox and 20mg/kg/day ascorbic acid) AOs decrease 3 weeks after deafening compared to those of untreated group. Asterisks indicate a significant difference (* p<0.05, **p<0.01).